Table 1.
Clinical features of the patients included in the study.
| Control (n = 15) | ADT patients (n = 49) | p-value | |
|---|---|---|---|
| Age (years) | 73.5 (SD = 6.4) | 78.2 (SD = 7.6) | 0.163 |
| Hypertension | 60.0% (9) | 69.4% (34) | 0.619 |
| Diabetes | 20.0% (3) | 46.9% (23) | 0.205 |
| Hypercholesterolemia | 26.6% (4) | 38.8% (19) | 0.751 |
| Smoking status | |||
| Active smoking | 6.6% (1) | 8.2% (4) | 0.888 |
| History of smoking | 40.0% (6) | 53.1% (26) | |
| Metastasis | 26.6% (4) | 34.7% (17) | 1.000 |
| ECOG (0–1) | 66.6% (10) | 87.7% (43) | 0.042 |
| Academic degree | |||
| No studies/primary | 46.6% (7) | 65.3% (32) | 0.525 |
| Secondary/superior | 53.3% (8) | 34.7% (17) | |
| Patients with at least 2 tests below − 1.5 SD | 73.3% (11) | 89.8% (44) | 0.630 |
| Patients with at least 1 test below − 2.0 SD | 80.0% (12) | 100% (49) | 0.210 |
| Depression (moderate–severe) | 6.6% (1) | 6.1% (3) | 0.681 |
Continuous variables were compared using the Mann–Whitney U test, while discrete variables were compared using the Chi-Square test (level of significance p = 0.05).